Taiwan Hopax Chemsistry MFG Co Ltd (6509) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Taiwan Hopax Chemsistry MFG Co Ltd stock TWD 48.86, price TWD 45.85, upside +6.6%, quality 67 out of 100. Rating: fairly valued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 25.75 TWD – 75.05 TWD · fair‑value band 36.64 TWD – 61.07 TWD · the 45.85 TWD price screens below the 48.86 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Taiwan Hopax Chemsistry MFG Co in your weekly email
Every Wednesday you see whether Taiwan Hopax Chemsistry MFG Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Taiwan Hopax Chemicals Manufacturing Co., Ltd. manufactures, processes, and sells chemical raw materials for pharmaceutical, industrial, paper making, and office stationery industries in Taiwan, rest of Asia, Europe, America, and internationally.
Show moreShow less
It operates through Specialty Chemicals, Fine Chemicals, Office Stationery, and Other segments.
The company offers paper making chemicals, such as hollow resins, dispersant, lubricants, anionic (cationic) surface sizing agent, ultra-fine dispersant for wet-grinding calcium carbonate, medium alkaline sizing agent, anion neutralizing agent, cohesion enhancer, retention and drainage aid, and titanium dioxide dispersant; and chemical materials for water treatment, including polymers, COD removal agent, fly ash curing agent, metal capturing agent, polyaluminum chloride, sedimentation control agent, geotechnical stabilizer, chelating agent, and dispersant.
It also provides NCR chemicals comprising NTR, color developers, microcapsules, spacer, wall materials, and emulsifiers; fine chemicals, including biological cleaning agents, biological buffers, waterborne polyurethane, sulfonate chain modifiers, additives for electroplating and lithium-ion batteries, and aldehyde removal additives; office supplies, such as repositionable self-adhesive products (Stick'N), self-adhesive markers and tapes, sticky products for education purposes, and customized sticky products; and de-formaldehyde removal products, anti-bacterial, home cleaning, pet care, and NBC mesh products.
In addition, the company provides office stationery, medical supplies, and biotechnology, as well as engages in investment activities. The company was formerly known as Taiwan Hopax Chemical Industrial Co., Ltd. and changed its name to Taiwan Hopax Chemicals Manufacturing Co., Ltd. in October 1996.
Taiwan Hopax Chemicals Manufacturing Co., Ltd. was incorporated in 1975 and is headquartered in Kaohsiung, Taiwan.
Stock analysis
Taiwan Hopax Chemsistry MFG Co Ltd (6509) currently trades at 45.85 TWD, while our model-based Fair Value estimate is 48.86 TWD, so the stock looks roughly fairly valued today (gap 6.2%).
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 53.58 TWD per share, and 12 of the 25 models we run sit above the 45.85 TWD price.
Bear case: the Asset-Based group reads lowest at 7.36 TWD, and 13 of the 25 models stay below the price. Data coverage for this calculation is high.
Scenario range: 36.64 TWD (bear) to 61.07 TWD (bull), the price of 45.85 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 67/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Taiwan Hopax Chemsistry MFG Co Ltd reported revenue of 4.9B TWD in FY2025 versus 4.7B TWD in FY2021, a compound +0.8%/yr. Reported net income was 567M TWD in FY2025, compounding +7.3%/yr from FY2021.
Key figures
Market cap 9.0B TWD (≈ $274M) Micro · P/E ratio 13.4 · P/S ratio 1.80 · EPS (TTM) 3.42 TWD · Dividend yield 3.1% · Net margin 14.2% · Return on equity 13.8% · Return on assets (EBIT) 9.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 61 out of 100 (low confidence).
What moves the price
The share trades about 20% below its 52-week high and 51% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −43% fair-value upside, at 7%, 6509 screens cheaper than that median.
Fair Value models
Bear36.64 TWDFair Value 48.86 TWDBull61.07 TWD
Price 45.85 TWD · Upside +6.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (1.73 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+2.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−3.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.3%
Start year 2020 (pandemic). Over 10 years: +4.5% a year
Revenue growth 16 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+15.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+12.1%
Dividend (yield on the price)3.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.12.1% vs 18.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.11% → 17%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+3.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +2.2% a year for the price.
Compare Taiwan Hopax Chemsistry MFG Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 728 stocks
Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score67 · Top 25%
Fair Value upside+6.6% · Above median
Profitability
Return on equity (12 months)13.8% · Top 25%
Return on assets7.2% · Top 25%
Net margin (12 months)14.2% · Top 25%
Operating margin (12 months)20.1% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)4.3% · Below median
Dividend yield (12 months)3.1% · Top 25%
Balance sheet
Debt / equity0.02× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (12 months)13.4× · Cheaper than median
P/B1.72× · Pricier than median
P/S (12 months)1.80× · Pricier than median
Price / free cash flow (fiscal year)10.9× · Cheaper than median
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Taiwan Hopax Chemsistry MFG Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/6509
Frequently asked questions
Is Taiwan Hopax Chemsistry MFG Co Ltd (6509) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 48.86 TWD versus a price of 45.85 TWD, about +7% upside (fairly valued).
What is the fair value of 6509?
Our model-based fair value for Taiwan Hopax Chemsistry MFG Co Ltd is 48.86 TWD (as of Nov 8, 2026), built from audited fundamentals. The current price: 45.85 TWD.
What is the quality score of 6509?
Taiwan Hopax Chemsistry MFG Co Ltd has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Our model-based price target is the fair value of 48.86 TWD (as of Nov 8, 2026) from 25 valuation models. Cautious scenario 36.64 TWD, optimistic scenario 61.07 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Taiwan Hopax Chemsistry MFG Co Ltd stock forecast for 2026?
Our models put fair value at 48.86 TWD, about +7% upside versus a price of 45.85 TWD (fairly valued). Cautious scenario 36.64 TWD, optimistic scenario 61.07 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Taiwan Hopax Chemsistry MFG Co Ltd reported trailing-twelve-month revenue of about 5.0B TWD (latest available figure, as of Nov 8, 2026).
Does Taiwan Hopax Chemsistry MFG Co Ltd pay a dividend?
Taiwan Hopax Chemsistry MFG Co Ltd currently shows a dividend yield of 3.05% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Taiwan Hopax Chemsistry MFG Co Ltd (6509) and when is the ex-dividend date?
Taiwan Hopax Chemsistry MFG Co Ltd pays a dividend of 1.40 TWD per share a year, a dividend yield of 3.1%. The last ex-dividend date was Jul 30, 2026. A dividend has been paid every year since 2010. The payout ratio is 40.9% of earnings. Free cash flow covers the dividend 2.98 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What growth is priced into Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
For today's price to be fair in a discounted-cash-flow model, Taiwan Hopax Chemsistry MFG Co Ltd would have to grow free cash flow by +3.8 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +6.3 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 6509 use?
Our models discount Taiwan Hopax Chemsistry MFG Co Ltd at 11.8 %: a base by market capitalisation (micro), damped by beta 0.57, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Taiwan Hopax Chemsistry MFG Co Ltd that is +3.8 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Taiwan Hopax Chemsistry MFG Co Ltd (6509) delivered so far?
Over the past 5 years revenue at Taiwan Hopax Chemsistry MFG Co Ltd grew +6.3 % a year. The price currently implies free-cash-flow growth of +3.8 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Taiwan Hopax Chemsistry MFG Co Ltd (6509) growing?
The median revenue growth in the sector is +9.8 % a year. That is the yardstick for the growth priced into Taiwan Hopax Chemsistry MFG Co Ltd (+3.8 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The free-cash-flow yield on the price is 9.14 %: that much free cash flow Taiwan Hopax Chemsistry MFG Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Taiwan Hopax Chemsistry MFG Co Ltd it is 48.86 TWD per share (as of Nov 8, 2026), against a price of 45.85 TWD. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Taiwan Hopax Chemsistry MFG Co Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 6509 trades below its calculated fair value: price 45.85 TWD, fair value 48.86 TWD, a gap of about +7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 6509?
No. The price is what the market pays today (45.85 TWD); the fair value is what the company's own numbers justify (48.86 TWD). For Taiwan Hopax Chemsistry MFG Co Ltd the two are 3.01 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Taiwan Hopax Chemsistry MFG Co Ltd worth?
The market values Taiwan Hopax Chemsistry MFG Co Ltd at about 9.0B TWD (market capitalisation, as of Nov 8, 2026). Per share that is 45.85 TWD; our models calculate a fair value of 48.86 TWD per share.
What do the bullish and bearish scenarios say about 6509?
Our models span a range for Taiwan Hopax Chemsistry MFG Co Ltd: cautious scenario 36.64 TWD, base 48.86 TWD, optimistic 61.07 TWD per share (as of Nov 8, 2026, price 45.85 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 6509?
Taiwan Hopax Chemsistry MFG Co Ltd trades at a price-to-earnings ratio of 13.4 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 48.86 TWD is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 16.8. Other multiples: P/B 1.7, P/S 1.8, EV/EBITDA 5.8.
How solid is the balance sheet of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Balance-sheet figures for Taiwan Hopax Chemsistry MFG Co Ltd (as of Nov 8, 2026): return on equity 13.8%, debt of 0.02 per unit of equity. They feed the Quality Score of 67/100, which measures business quality independently of the share price.
How far is 6509 from its 52-week high?
Taiwan Hopax Chemsistry MFG Co Ltd trades at 45.85 TWD, about 20% below its 52-week high of 57.50 TWD and 51% above the low of 30.30 TWD (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 48.86 TWD is for.
Which stocks are comparable to Taiwan Hopax Chemsistry MFG Co Ltd?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Taiwan Hopax Chemsistry MFG Co Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price 45.85 TWD, calculated fair value 48.86 TWD (+7%), Quality Score 67/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 6509 calculated?
We run Taiwan Hopax Chemsistry MFG Co Ltd through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 48.86 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Taiwan Hopax Chemsistry MFG Co Ltd currently trades 6% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The closing price on Nov 6, 2026 was 45.85 TWD. Our model-based fair value is 48.86 TWD, about +7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Taiwan Hopax Chemsistry MFG Co Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of Taiwan Hopax Chemsistry MFG Co Ltd (6509) come from?
Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd grew +19.6 % a year from 2012 to 2023. Broken into its drivers: revenue per share +3.6 %, EBIT margin +13.6 %, tax rate +3.9 %, residual (interest, one-offs) −2.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Taiwan Hopax Chemsistry MFG Co Ltd
How large is the market capitalisation of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The market capitalisation of Taiwan Hopax Chemsistry MFG Co Ltd is 9.0B TWD (≈ $274M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The price-to-sales ratio of Taiwan Hopax Chemsistry MFG Co Ltd is 1.80 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd are 3.42 TWD (price ÷ EPS = P/E 13.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The dividend yield of Taiwan Hopax Chemsistry MFG Co Ltd is 3.1% (payout 40.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The net margin of Taiwan Hopax Chemsistry MFG Co Ltd is 14.2% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The return on equity (ROE) of Taiwan Hopax Chemsistry MFG Co Ltd is 13.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
On an EBIT basis the return on assets of Taiwan Hopax Chemsistry MFG Co Ltd is 9.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
The operating margin of Taiwan Hopax Chemsistry MFG Co Ltd is 20.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Revenue at Taiwan Hopax Chemsistry MFG Co Ltd is growing +4.3% versus a year earlier (3y avg −3.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Taiwan Hopax Chemsistry MFG Co Ltd (6509)?
Earnings per share at Taiwan Hopax Chemsistry MFG Co Ltd are growing +59.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Taiwan Hopax Chemsistry MFG Co Ltd (6509) carry?
The net debt of Taiwan Hopax Chemsistry MFG Co Ltd is 810M TWD (fiscal year 2023, ≈ 1.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Taiwan Hopax Chemsistry MFG Co Ltd in the live analysis
One click puts Taiwan Hopax Chemsistry MFG Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026